1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Barriers to a career focus in cancer prevention: A report and initial recommendations from the American Society of Clinical Oncology Cancer Prevention Workforce Pipeline Work Group
    Journal Article

    Fabian, C. J.; Meyskens, F. L. Jr; Bajorin, D. F.; George, T. J. Jr; Jeter, J. M.; Khan, S.; Tyne, C. A.; William, W. N. Jr
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Long-term safety of sunitinib in metastatic renal cell carcinoma
    Journal Article

    Porta, C.; Gore, M. E.; Rini, B. I.; Escudier, B.; Hariharan, S.; Charles, L. P.; Yang, L.; Deannuntis, L.; Motzer, R. J.
    European Urology (2016)

    Fulltext@MSK | Save
  • Molecular signature of response to pazopanib salvage therapy for urothelial carcinoma
    Journal Article

    Pinciroli, P.; Won, H.; Iyer, G.; Canevari, S.; Colecchia, M.; Giannatempo, P.; Raggi, D.; Pierotti, M. A.; De Braud, F. G.; Solit, D. B.; more...
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Bevacizumab monotherapy as salvage therapy for advanced clear cell renal cell carcinoma pretreated with targeted drugs
    Journal Article

    Lee, C. H.; Hötker, A. M.; Voss, M. H.; Feldman, D. R.; Woo, K. M.; Patil, S.; Coskey, D. T.; Akin, O.; Hsieh, J. J.; Motzer, R. J.
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
    Journal Article

    Goldstein, D.; Rosenberg, J. E.; Figlin, R. A.; Townsend, R. R.; McCann, L.; Carpenter, C.; Pandite, L.
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • The molecular taxonomy of primary prostate cancer
    Journal Article

    The Cancer Genome Atlas Research Network
    Cell (2015)

    Fulltext@MSK | Save
  • Clinical trials and emerging therapeutic strategies in bladder cancer
    Book Section

    Bambury, R. M.; Sims, R. B.; Rosenberg, J. E.
    In Konety, B. R.; Chang, S. S. (Eds.) Management of Bladder Cancer: A Comprehensive Text With Clinical Scenarios (2015)

    Fulltext@MSK | Save
  • New molecular markers with diagnostic and prognostic values in bladder cancer
    Book Section

    Al-Ahmadie, H. A.; Iyer, G.
    In Magi-Galluzzi, C.; Przybycin, C. G. (Eds.) Genitourinary Pathology: Practical Advances (2015)

    Fulltext@MSK | Save
  • Genetic and epigenetic alterations in urothelial carcinoma
    Book Section

    Al-Ahmadie, H. A.; Iyer, G.
    In Magi-Galluzzi, C.; Przybycin, C. G. (Eds.) Genitourinary Pathology: Practical Advances (2015)

    Fulltext@MSK | Save
  • CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - A phase I study
    Meeting Abstract

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Autio, K. A.; Wong, D. J.; Falchook, G. S.; Patel, M. R.; Pant, S.; Whiteside, M.; Bendell, J.; more...
    Journal for ImmunoTherapy of Cancer (2015)

    Fulltext@MSK | Save